TRANS-HERBA AS
Operating
Forskning, utvikling, produksjon og salg av biomolekyler i transgene
planter (så som rekombinante antigener til vaksinefremstilling og
diagnostisk bruk, rekombinante antistoffer til diagnostisk og
terapeutisk bruk), og andre produkter som naturlig faller sammen med
dette.
Organization
- CEO
- VB
Vidar Bakken1950
- Chairman of the board
- KO
- Years since formation
- 27 years
- since Jun 23, 1998
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 4
- persons
Financials
- Total operating income 2024
- 600,000
- NOK
- Annual total result 2024
- 527,303
- NOK
- Total equity 2024
- 335,437
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
VB 1950 | Managing Director/CEO | 25 % directly |
Board
| Name | Role | Shares |
|---|---|---|
KO | Chairman | 25 % directly |
VB 1950 | Board Member | 25 % directly |
AH | Board Member | 25 % directly |
GS 1959 | Board Member | 25 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
KO | Chairman | 25 % directly |
AH | Board Member | 25 % directly |
GS 1959 | Board Member | 25 % directly |
VB 1950 | Managing Director/CEO, Board Member | 25 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
AH | Ordinary shares | 250 | 25 % |
GS 1959 | Ordinary shares | 250 | 25 % |
KO | Ordinary shares | 250 | 25 % |
VB 1950 | Ordinary shares | 250 | 25 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 600,000 | 0 | 0 | 0 |
Annual Total Result | 527,303 | -1,256 | -50,817 | -10,328 |
Total assets | 604,070 | 1,696 | 905 | 4,701 |
Total liabilities | 268,633 | 193,562 | 191,514 | 144,494 |
Total equity | 335,437 | -191,866 | -190,610 | -139,793 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 600,000 | 0 | 0 | 0 |
Total operating costs | 13,678 | 1,259 | 50,818 | 10,328 |
Operating result | 586,322 | -1,259 | -50,818 | -10,328 |
Financial income/costs | 52 | 3 | 1 | 0 |
Profit before tax | 586,374 | -1,256 | -50,817 | -10,328 |
Total tax & extraordinary income/cost | 59,071 | 0 | 0 | 0 |
Annual Total Result | 527,303 | -1,256 | -50,817 | -10,328 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 604,070 | 1,696 | 905 | 4,701 |
Total assets | 604,070 | 1,696 | 905 | 4,701 |
Short term debt | 268,633 | 193,562 | 191,514 | 144,494 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 268,633 | 193,562 | 191,514 | 144,494 |
Contributed capital | 100,000 | 100,000 | 100,000 | 100,000 |
Retained earnings | 235,437 | -291,866 | -290,610 | -239,793 |
Total equity | 335,437 | -191,866 | -190,610 | -139,793 |
Total equity and liabilities | 604,070 | 1,696 | 905 | 4,701 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises